{"id":400937,"date":"2026-10-20T04:24:46","date_gmt":"2026-10-20T04:24:46","guid":{"rendered":"https:\/\/bizscoreai.com\/blog\/google-tests-pharmaceutical-ads-in-ai-mode-and-ai-overviews\/"},"modified":"2026-10-24T09:33:02","modified_gmt":"2026-10-24T09:33:02","slug":"google-tests-pharmaceutical-ads-in-ai-mode-and-ai-overviews","status":"publish","type":"post","link":"https:\/\/bizscoreai.com\/blog\/google-tests-pharmaceutical-ads-in-ai-mode-and-ai-overviews\/","title":{"rendered":"Google Tests Pharmaceutical Ads In AI Mode And AI Overviews"},"content":{"rendered":"

Google is running a limited test that places standard text and Shopping ads for certain pharmaceutical products inside AI Mode and AI Overviews, opening a new advertising surface for prescription drug brands and opening a new kind of result for searchers to read past.<\/p>\n

A Google spokesperson told Adweek that the test now includes “certain pharmaceutical products” within those AI surfaces. The stated phrasing: “We’re testing standard text and Shopping ads in AI Mode and AI Overviews, which we recently expanded to include certain pharmaceutical products.” These ads, when they appear, are placed inside sections clearly labeled “Sponsored.”<\/p>\n

What Google is actually testing<\/h2>\n

The test expands the ad formats that Google already runs inside AI Mode and AI Overviews. Standard text ads and Shopping ads have appeared inside those surfaces during earlier rounds of testing; the new piece of the test is the inclusion of pharmaceutical products, with prescription drugs named as a category now eligible.<\/p>\n

Reporting places the start of the pharmaceutical testing inside AI Mode and AI Overviews in October 2026, and limits participation to the United States. The appearance rule is consistent with Google’s existing approach for ads in these AI surfaces: the ad blocks are visually separated from the AI-generated answer and labeled “Sponsored.” That label is how a reader can tell that the block below or beside the AI summary is paid placement rather than a recommendation that came out of the model.<\/p>\n

Google declined to point to a recent policy change covering pharmaceutical advertising in AI Mode or AI Overviews. The public Google Ads drug and pharmaceutical policies were last visibly updated in March 2026 and in October 2025, with a handful of country-specific changes mixed in over the prior year. Asked for confirmation, a Google representative said there were no recent policy updates on this point and framed the move as an expansion of the existing AI surfaces test rather than a policy change.<\/p>\n

Who can buy the ads, and where they appear<\/h2>\n

Pharmaceutical advertisers approved under Google’s existing policies can run standard text ads and Shopping ads inside the two AI surfaces during the test. The eligible category spans prescription drugs and the broader “certain pharmaceutical products” bucket Google used in its statement. Google has not published a definitive list of every product type included, which leaves room for narrower categories (such as brand-name drugs, generics, over-the-counter treatments, or telehealth-adjacent products) to be quietly included or excluded inside the same “certain” umbrella.<\/p>\n

Geographically, the test is U.S.-only at launch. Google has not said how long the regional limit will stay in place, and similar earlier tests of ads in AI Mode and AI Overviews have run in limited geographies for extended stretches before broader rollout decisions.<\/p>\n

What it looks like to a searcher<\/h2>\n

For the person doing the searching, the layout mirrors what Google has already shipped elsewhere in AI Mode and AI Overviews. The AI-generated summary sits at the top of the AI surface, links to sources sit beneath the summary in the standard format, and the ad slots carry the explicit “Sponsored” label. For a query where the AI summary touches on a condition, treatment, or drug, the ad blocks can sit right next to or directly under the answer, with the visual separation supplied by the “Sponsored” tagging and the standard ad formatting.<\/p>\n

Worth noting is that ads appearing in or next to a generated answer about a drug or condition tend to draw more attention than ads tucked into a regular results page, because the reader is already reading answer-shaped content in that block. The “Sponsored” label is the only separation between the AI’s own suggestions and the paid placement for the same query.<\/p>\n

Why advertisers are watching this<\/h2>\n

Pharmaceutical advertisers have spent years operating in tightly restricted ad environments. Google’s drug policies have historically gated the kinds of claims, the kinds of landing pages, and even the kinds of wording a brand can run, on top of any FDA or regional rules. Expanding the ad inventory to two AI-first surfaces doesn’t loosen those policies on its own; what it changes is where an approved pharmaceutical ad can show up. For brands already cleared by Google, that adds two new placements to a media plan that has been mostly search-results-and-display up to this point.<\/p>\n

For agencies and brand leads watching the AI Mode and AI Overviews ad tests, three signals to watch are: which product categories move from “certain” to a longer named list, whether the U.S. limit lifts, and whether ad measurement reports in Google Ads break out AI-Mode and AI-Overviews impressions the way they break out standard search surfaces today.<\/p>\n

What it looks like on the search page today<\/h2>\n

Independent checks during the first stretch of the test did not surface pharmaceutical ads inside every AI Mode or AI Overview result. The combination of limited inventory, the U.S.-only launch, and the fact that pharmaceutical ads only show up on queries where a brand has bid and won an auction means that most searchers running ad-hoc checks still see a clean AI summary with no pharmaceutical ad block beneath it. As more advertisers enter the test and broader queries get covered, expect to see “Sponsored” blocks adjacent to AI-generated health summaries more often.<\/p>\n

Key facts to remember<\/h2>\n